Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 176
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
atai Life Sciences Reports Second Quarter 2022 Financial Results & Business...
FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction...
atai Life Sciences Secures Term Loan Facility for up to $175...
Field Trip Announces Closing of Plan of Arrangement and $19.9 Million...
PsyBio Therapeutics Strengthens IP Portfolio through Filing of Data to Support...
Psychedelic Bulletin #114 – Lawsuit Alleges Compass Stole Trade Secrets; MindMed...
Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved...
MindMed Strengthens Board with Appointment of Two New Independent Directors
Opinions | Hallucinations of Meaning: If you can lie, so can...
Load more
